| Clinical data | |
|---|---|
| Other names | 4-Butylthio-2,5-dimethoxyphenethylamine; 2,5-Dimethoxy-4-butylthiophenethylamine; 2C-T-Bu |
| Routes of administration | Unknown[1] |
| ATC code |
|
| Pharmacokinetic data | |
| Duration of action | Unknown[1] |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider |
|
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C14H23NO2S |
| Molar mass | 269.40 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
2C-T-19, also known as 4-butylthio-2,5-dimethoxyphenethylamine, is a possible psychedelic drug of the phenethylamine and 2C families.[1]
Use and effects
In his book PiHKAL (Phenethylamines I Have Known and Loved), Alexander Shulgin describes synthesis of the final intermediate of 2C-T-19 but did not bioassay the compound.[1]
Society and culture
Legal status
Canada
As of October 31, 2016, 2C-T-19 is a controlled substance (Schedule III) in Canada.[2]
United States
In the United States, 2C-T-19 is not specifically scheduled, but possession and sales of 2C-T-19 could be prosecuted under the Federal Analog Act because of its structural similarities to 2C-T-7.
See also
References
- Shulgin AT, Shulgin A (1991). "2C-T-19". PiHKAL: A Chemical Love Story (1st ed.). Berkeley, CA: Transform Press. ISBN 978-0-9630096-0-9. OL 22859055M.
- "Regulations Amending the Food and Drug Regulations (Part J — 2C-phenethylamines)". Canada Gazette. Vol. 150, no. 9. 4 May 2016.